These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 3260709)

  • 1. Cytotoxic activity of lymphocyte subpopulations against autologous tumour cells in patients with myeloid leukaemias and preleukaemic disorders.
    Szabó B; Váczi L; Tóth FD; Kiss J; Kiss A; Rák K
    Acta Microbiol Hung; 1988; 35(1):25-33. PubMed ID: 3260709
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cytotoxicity of lymphocytes and antibodies against autologous tumor cells in patients with myeloid leukaemias and preleukaemic disorders. III. Stage-dependence of oncovirus-specific immune response.
    Szabó B; Tóth FD; Váczi L; Kiss J; Réthy A; Kiss A; Rák K
    Acta Microbiol Hung; 1986; 33(2):103-10. PubMed ID: 3492851
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cellular and humoral cytotoxicity in patients with leukaemia and preleukaemia. II. Oncovirus specificity of the reaction.
    Szabó B; Tóth FD; Váczi L; Réthy A; Kiss A; Rák K
    Acta Microbiol Hung; 1984; 31(4):365-72. PubMed ID: 6085606
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cytotoxicity of lymphocytes and antibodies against autologous tumor cells in patients with myeloid leukemias and preleukemic disorders. I. Blocking activity of gp70 antigens of primate type C viruses.
    Szabó B; Tóth FD; Váczi L; Réthy A; Kiss A; Rák K
    Neoplasma; 1983; 30(2):129-35. PubMed ID: 6302527
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Studies on the specificity of human antibodies reacting with GP70 and P15 antigens of baboon endogenous (BaEV) and gibbon ape leukaemia (GaLV) viruses.
    Tóth FD; Váczi L; Szabó B; Réthy A; Rák K; Kiss J; Kiss A
    Acta Virol; 1984 May; 28(3):191-7. PubMed ID: 6147994
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Studies on antigens of C-type primate viruses and antibodies to them at patients with myeloid leukemia and potentially preleukemic hematological disorders.
    Váczi L; Tóth FD
    Arch Geschwulstforsch; 1980; 50(8):769-77. PubMed ID: 6261716
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Studies on antibodies reactive with glycoproteins of primate type C viruses in patients with myeloid leukemias and with potential preleukemia.
    Tóth FD; Váczi L; Réthy A; Szabó B; Kiss J; Kiss A; Rák K
    Neoplasma; 1982; 29(4):397-401. PubMed ID: 6290914
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dendritic cells fused with core binding factor-beta positive acute myeloid leukaemia blast cells induce activation of cytotoxic lymphocytes.
    Banat GA; Usluoglu N; Hoeck M; Ihlow K; Hoppmann S; Pralle H
    Br J Haematol; 2004 Aug; 126(4):593-601. PubMed ID: 15287954
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Specificity of heteroantisera to human acute leukemia-associated antigens.
    Baker MA; Ramachandar K; Taub RN
    J Clin Invest; 1974 Dec; 54(6):1273-8. PubMed ID: 4140196
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expansion of cytotoxic effectors with lytic activity against autologous blasts from acute myeloid leukaemia patients in complete haematological remission.
    Torelli GF; Guarini A; Palmieri G; Breccia M; Vitale A; Santoni A; Foa R
    Br J Haematol; 2002 Feb; 116(2):299-307. PubMed ID: 11841430
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fusion hybrids of dendritic cells and autologous myeloid blasts as a potential cellular vaccine for acute myeloid leukaemia.
    Klammer M; Waterfall M; Samuel K; Turner ML; Roddie PH
    Br J Haematol; 2005 May; 129(3):340-9. PubMed ID: 15842657
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression of blood group-like antigens on the T lymphocytes of acute leukaemia patients in remission.
    Pullen S; Hersey P
    Clin Exp Immunol; 1980 Feb; 39(2):403-10. PubMed ID: 6966993
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Leukemia-derived dendritic cells can be generated from blood or bone marrow cells from patients with acute myeloid leukaemia: a methodological approach under serum-free culture conditions.
    Kufner S; Zitzelsberger H; Kroell T; Pelka-Fleischer R; Salem A; de Valle F; Schweiger C; Nuessler V; Schmid C; Kolb HJ; Schmetzer HM
    Scand J Immunol; 2005 Jul; 62(1):86-98. PubMed ID: 16091128
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lactate dehydrogenase-release assay: a reliable, nonradioactive technique for analysis of cytotoxic lymphocyte-mediated lytic activity against blasts from acute myelocytic leukemia.
    Weidmann E; Brieger J; Jahn B; Hoelzer D; Bergmann L; Mitrou PS
    Ann Hematol; 1995 Mar; 70(3):153-8. PubMed ID: 7718644
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Specific antibodies to viruses HL-23 and BILN in the blood plasma of patients with acute myelogenous leukaemia and with potential preleukaemia.
    Tóth FD; Kiss J; Váczi L; Madár Z; Jakó J; Rák K
    Acta Microbiol Acad Sci Hung; 1980; 27(2):147-53. PubMed ID: 6251702
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Detection by radioimmunoassay of antigens related to the P30 polypeptides of primate type C oncoviruses in peripheral leukocytes from patients with chronic myelogenous leukaemia.
    Tóth FD; Váczi L; Kiss J; Réthy A; Kiss A; Rák K
    Acta Virol; 1981 Nov; 25(6):376-80. PubMed ID: 6120639
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Suppression of lymphoproliferative responses to alloantigens by autologous AML cells.
    Taylor GM; Fergusson WD; Harris R
    Clin Exp Immunol; 1979 Jan; 35(1):53-61. PubMed ID: 154982
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antiretroviral immune response and plasma interferon in different phases of chronic granulocytic leukemia.
    Szabó B; Tóth FD; Kiss J; Kiss A; Rák K
    Leuk Res; 1993 Apr; 17(4):311-23. PubMed ID: 7683737
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Induction of leukemia-specific cytotoxic response by cross-presentation of late-apoptotic leukemic blasts by autologous dendritic cells of nonleukemic origin.
    Spisek R; Chevallier P; Morineau N; Milpied N; Avet-Loiseau H; Harousseau JL; Meflah K; Gregoire M
    Cancer Res; 2002 May; 62(10):2861-8. PubMed ID: 12019165
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Foetal antigens on leukaemia cells (author's transl)].
    Thränhardt H; Zintl F; Milleck J; Plenert W
    Arch Geschwulstforsch; 1978; 48(8):750-5. PubMed ID: 288321
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.